Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for cyclosporine-induced hyperuricemia in children with aplastic anemia
ChiCTR2200056659Phase 4Not yet recruiting
- Sponsor
- The Seventh Affiliated Hospital, Sun Yat-sen University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hyperuricemia comparing Allopurinol group with Placebo group (2 arms). Primary endpoint: Change in blood uric acid concentration from baseline to week 24. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
allopurinol
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR2200056659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200056659.